GL1X · GenesisL1 explorer

MolNFT v1 · #125249 · protein

LSD1-COREST1 in complex with quinazoline-derivative reversible inhibitor

5L3E: “LSD1-COREST1 in complex with quinazoline-derivative reversible inhibitor”. X-ray diffraction, 3 ligands (E11, FAD, NA). MolNFT v1 #125249 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5L3E
Type
protein
Length
799 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O60341, Q9UKL0
Ligands
E11, FAD, NA

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein666—O60341
B—protein133—Q9UKL0

Ligands and binding sites

  • E11 · N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino) propyl]-6,7-dimethoxyquinazoline-2,4-diamine · ligand · 5 copies · chains A
  • FAD · Flavin-adenine dinucleotide · ligand · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5L3E · LSD1-CoREST1 in complex with quinazoline-derivative reversible inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UKL0 · AlphaFold monomer V2.0 prediction for rest corepressor 1 (Q9UKL0) · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.